spacer
home > epc > spring 2018 > a winning formula
PUBLICATIONS
European Pharmaceutical Contractor

A Winning Formula

Considerable discussion has been had about the concept of patient centricity in the pharmaceutical community. The industry has taken a collective pause in an effort to re-evaluate longstanding approaches to drug development and commercialisation, with attention being recalibrated on the ultimate goal: making reaching improved health outcomes easier for the patient. This perspective is underpinned by the recognition that what is best for the patient will lead to beneficial outcomes for all stakeholders, including the drug company, the healthcare provider, and supporting community of associated service providers.

A famous quote from former US Surgeon General, C Everett Koop states “Drugs don’t work in people who don’t take them”. Less than one-third of all prescriptions written are estimated to be filled at the pharmacy by patients. Wide-ranging studies have shown medication adherence rates for life-threatening diseases including diabetes, heart disease, and oncology can be as low as 30-40%. With the benefit of interventional techniques and developing technologies, adherence rates have been shown to improve. However, these programmes are not broadly adopted with scale and have not had significant impact decreasing the overall cost of healthcare nor benefitted large populations.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Justin Schroeder is Senior Executive Director of global marketing and design at PCI Pharma Services. He is responsible for global marketing, creative package design, and new account development, with a focus on the development and commercialisation of new products. Justin has over 20 years of experience in outsourced pharma services in various roles, including engineering, project management, marketing, and development. He holds a Bachelor of Science from the School of Packaging at Michigan State University, US, and an MBA in marketing from Northern Illinois University, US. Justin is a certified Packaging Professional from the Institute of Packaging Professionals, US, and is the Vice Chairman of the US Healthcare Compliance Packaging Council.
spacer
Justin Schroeder
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

CPhI expert forecasts ‘huge growth in Middle East manufacturing with Europe a medium-term target’

CPhI Middle East & Africa (CPhI MEA) expert Madhukar Tanna, Chief Executive Officer of Pharmax, a United Arab Emirates (UAE) based branded generic manufacturer, says favourable conditions in the UAE are resulting in a boom of pharmaceutical manufacturing throughout the region. Government incentive schemes to increase domestic production, coupled with a brand friendly environment and rising healthcare needs is fuelling surging demand – with many new companies and plants launching in the last two years alone.
More info >>

White Papers

Driving ROI: The Case for Investing in Contract & Site Regulatory Document Management Services

DrugDev

With tight timelines and complicated regulatory documentation requirements, getting a clinical trial up and running quickly is easier said than done. Key milestones can be achieved only after the successful negotiation of clinical trial agreements and completion of essential regulatory documents. Many clinical trials are hindered by inefficient, labor-intensive processes. Prolonged, inefficient activation can hamper investigator satisfaction and, ultimately, have a negative bottom-line impact for sponsors and CROs. In addition, the Sunshine Act is heightening the importance of financial disclosure in clinical trials. Without a robust financial disclosure strategy, sponsors cannot ensure that physician self-reported financial disclosure data are aligned with the payment data being reported through the Sunshine Act, increasing financial and regulatory risk.
More info >>

 
Industry Events

PDA Europe Annual Meeting 2019

24 June 2019, Hilton Amsterdam

Featuring updates from international regulatory agencies as well as industry, this promises to become another highlight in the 2019 event calendar and is a meeting not to be missed!
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement